• 1
    Rush DN, Henry SF, Jeffery JR, Schroeder T, Gough J. Histological findings in early routine biopsies of stable renal allograft recipients. Transplantation 1994; 57: 208211.
  • 2
    Seron D, Moreso F, Bover J et al. Early protocol renal allograft biopsies and graft outcome. Kidney Int 1997; 51: 310316.
  • 3
    Legendre C, Thervet E, Skhiri H et al. Histological features of chronic allograft nephropathy revealed by protocol biopsies in kidney transplant recipients. Transplantation 1998; 65: 15061510.
  • 4
    Nankivell BJ, Borrows RJ, Fung CLS, O'Connell PO, Allen RDM, Chapman JR. The natural history of chronic allograft nephropathy. N Eng J Med 2003; 349: 23262333.
  • 5
    Schwarz A, Mengel M, Gwinner W et al. Risks factors for chronic allograft nephropathy after renal transplantation: A protocol biopsy study. Kidney Int 2005; 67: 341348.
  • 6
    Nankivell BJ, Borrows RJ, Fung CLS, O'Connell PO, Allen RDM, Chapman JR. Natural history, risk factors, and impact of subclinical rejection in kidney transplantation. Transplantation 2004; 78: 242249.
  • 7
    Rush D, Jeffery JR, Gough J. Sequential protocol biopsies in renal transplant patients. Clinico-pathological correlations using the Banff schema. Transplantation 1995; 59: 511514.
  • 8
    Seron D, Moreso F, Ramon JM et al. Protocol renal allograft biopsies and the design of clinical trials aimed to prevent or treat chronic allograft nephropathy. Transplantation 2000; 69: 18491855.
  • 9
    Gloor JM, Cohen AJ, Lager DJ et al. Subclinical rejection in tacrolimus treated renal transplant recipients. Transplantation 2002; 73: 19651968.
  • 10
    Moreso F, Seron D, Carrera M et al. Baseline immunosuppression is associated with histological findings in early protocol biopsies. Transplantation 2004; 78: 10641068.
  • 11
    Choi BS, Shin MJ, Shin SJ et al. Clinical significance of an early protocol biopsy in living-donor renal transplantation: Ten-year experience at a single center. Am J Transplant 2005; 5: 13541360.
  • 12
    Shishido S, Asanuma H, Nakai H et al. The impact of repeated subclinical acute rejection on the progression of chronic allograft nephropathy. J Am Soc Nephrol 2003; 14: 10461052.
  • 13
    Seron D, Moreso F, Fulladosa X, Hueso M, Carrera M, Grinyó JM. Reliability of chronic allograft nephropathy diagnosis in sequential protocol biopsies. Kidney Int 2002; 61: 727733.
  • 14
    Rush D, Nickerson P, Gough J et al. Beneficial effects of treatment of early subclinical rejection: A randomized study. J Am Soc Nephrol 1998; 9: 21292134.
  • 15
    Roberts ISD, Reddy S, Russell C et al. Subclinical rejection and borderline changes in early protocol biopsy specimens after renal transplantation. Transplantation 2004; 77: 11941198.
  • 16
    Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713723.
  • 17
    Miyagi M, Ishikawa Y, Mizuiri S, Aikawa A, Ohara T, Hasegawa A. Significance of subclinical rejection in early renal allograft biopsies for chronic allograft dysfunction. Clin Transplant 2005; 19: 456465.
  • 18
    Furness PN, Taub N. International variation in the interpretation of renal transplant biopsies: Report of the CERTPAP project. Kidney Int 2001; 60: 19982012.
  • 19
    Veronese FV, Mamfro RC, Roman FR et al. Reproducibility of the Banff classification in subclinical kidney transplant rejection. Clin Transplant 2005; 19: 518521.
  • 20
    Bates WD, Davies DR, Welsh K, Gray DWR, Fuggle SW, Morris PJ. An evaluation of the Banff classification of early renal allograft biopsies and correlation with outcome. Nephrol Dial Transplant 1999; 14: 23642369.
  • 21
    Cosio FG, Grande JP, Wadei H, Larson TS, Griffin MD, Stegall MD. Predicting subsequent decline in kidney allograft function from early surveillance biopsies. Am J Transplant 2005; 5: 11301136.
  • 22
    Melk A, Halloran PF. Cell senescence and its implications for nephrology. J Am Soc Nephrol 2001; 12: 385393.
  • 23
    Buehrig CK, Lager DJ, Stegall MD et al. Influence of surveillance renal allograft biopsy on diagnosis and prognosis of polyomavirus-associated nephropathy. Kidney Int 2003; 64: 665673.
  • 24
    Flechner SM, Kurian SM, Solez K et al. De novo kidney transplantation without use of calcineurin inhibitors preserves renal structure and function at two years. Am J Transplant 2004; 4: 17761785.
  • 25
    Ruiz JC, Campistol JM, Grinyo JM et al. Early cyclosporine A withdrawal in kidney transplant recipients receiving sirolimus prevents progression of chronic pathologic allograft lesions. Transplantation 2004; 78: 13121318.
  • 26
    Mota A, Arias M, Taskinen EI et al. Sirolimus-based therapy following early cyclosporine withdrawal provides significantly improved renal histology and function at 3 years. Am J Transplant 2004; 4: 953961.